Can monocytes predict CART cell success in myeloma?
NCT ID NCT07180992
First seen Nov 01, 2025 · Last updated Jun 12, 2026 · Updated 42 times
Summary
This study examines how certain immune cells called monocytes influence the effectiveness of CART cell therapy in people with multiple myeloma. Researchers will analyze blood samples before and after treatment to see if monocyte levels and types can predict how well the therapy works. The goal is to find early markers that help identify who will benefit most from CART cells.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for MULTIPLE MYELOMA are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
CHRU Amiens
RECRUITINGAmiens, France
Contact Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.